Forty Seven Stock
Clinical-stage immuno-oncology company
About Forty Seven Stock
With a passion for pioneering breakthrough solutions, we are committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.
Investors
Lightspeed Venture Partners
Snap, AppDynamics, Epic Games, LivingSocial, Affirm, Rubrik, Nutanix, ThoughtSpot, Guardant Health, TripActions
Sutter Hill Ventures
Pure Storage, Sumo Logic, C3 IoT, Sila Nanotechnologies, Glassdoor, Menlo Security, SiFive, Yext, Platfora, MATRIXX Software
Funding History
| February 2016 | $75.0M |
|---|
Management
Cofounder
Irving Weissman
Press
WSJ - Feb, 24 2016
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Forty Seven or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
